Software As A Medical Device

Software As A Medical Device is software that performs a medical function on its own or in combination with a device, including some mobile applications. Because it can influence diagnosis, treatment, or patient safety, it is subject to cybersecurity, privacy, and post-market vulnerability management expectations.

Expanded Definition

Software As A Medical Device, often shortened to SaMD, is software whose medical purpose is achieved without relying on a hardware device to do the medical work itself. That can include diagnostic, triage, monitoring, therapeutic, or decision-support software delivered through a phone, web service, or other computing platform.

The key boundary is intent and function. General wellness, scheduling, or administrative apps are not SaMD unless they make a medical claim or perform a medical function. Likewise, software embedded in a physical medical product may fall under a different regulatory treatment than stand-alone SaMD. Guidance versus consensus also matters here: regulators broadly align on the concept, but exact classification can vary by jurisdiction and by the software’s intended use.

For a practical orientation to the term, practitioners should read it as a regulated software category, not as a technology stack label. A common misunderstanding is assuming that “software plus clinical context” automatically makes a product SaMD, when the classification usually turns on intended medical purpose and the effect of the software’s output.

Examples and Use Cases

SaMD appears across clinical and consumer-facing workflows where software output affects care decisions. The same product can be low risk in one use case and material in another if the medical function changes.

• A mobile app that analyzes symptoms and suggests whether a patient should seek urgent care.
• Software that interprets imaging data and highlights suspected abnormalities for clinician review.
• An algorithm that adjusts or recommends therapy based on continuous health data.
• A remote monitoring platform that alerts clinicians to deterioration trends in a patient’s condition.
• A decision-support tool that classifies risk and influences diagnosis or treatment prioritization.

These examples show the tradeoff central to SaMD design: the more the software influences clinical judgment, the stronger the need for validation, traceability, and controlled updates. If a product only stores, transmits, or displays data without a medical function, it may sit outside SaMD even if it is used in a healthcare setting.

Security Implications

SaMD creates security implications because a software fault can become a patient safety issue, not just an IT issue. Integrity failures are especially important: altered inputs, corrupted models, unsafe updates, or broken dependencies can change outputs that clinicians or patients trust. Availability failures also matter because delayed access to a medical function can affect triage, monitoring, or treatment timing.

The operational consequence is that cybersecurity controls must protect both the software and the medical decision pathway it supports. A vulnerability in a connected component, update process, or cloud service can propagate into incorrect recommendations, missing alerts, or loss of confidence in the product. Post-market vulnerability handling is therefore part of safety assurance, not an optional add-on.

One practical observation is that SaMD teams often focus on feature correctness while underestimating the security impact of update cadence, telemetry quality, and third-party dependencies. When those supporting elements drift, the product can remain technically “available” while becoming clinically unreliable.

Domain and Governance Relevance

SaMD sits at the intersection of medical device governance, software assurance, and cybersecurity. Its primary domain is regulated health software, so the first question is whether the product’s intended use creates a medical claim or medical function. Once that threshold is met, security governance must support patient safety, evidence of control, and disciplined change management.

That governance lens changes how practitioners treat vulnerability disclosure, patching, and release control. A bug report is not just a defect ticket; it can become a safety and compliance issue that needs triage, risk assessment, and validation before remediation is deployed. For organisations building connected or cloud-delivered medical software, the software lifecycle itself becomes part of the assurance case.

NHI concepts are not the centre of SaMD classification, but they can become material where machine-to-machine services, API-driven telemetry, or automated agents participate in the product’s operation. In those cases, the trust boundary extends beyond the application into the identities and credentials that move clinical data and updates.

Related resources from NHI Mgmt Group

• How should healthcare teams govern connected medical device identity?
• What breaks when medical device security is only checked after release?
• Who is accountable for medical device cybersecurity in healthcare?
• How should teams reduce the blast radius of a compromised medical device?